Get Breaking Health News headlines emailed to you daily.
Start Of Phase I/ii Gene Therapy Clinical Trial For Hemophilia B Source: Medical News Today Thursday 11th March, 2010
0 posts Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced that the first patient has been dosed in the Phase I/II exploratory clinical trial with... ...
